Stemline Therapeutics (STML) PT Lowered to $23 at Piper Jaffray
Tweet
Share
E-mailGet Alerts STML Hot Sheet
Price: $11.83 --0%
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Piper Jaffray analyst Joseph Catanzaro lowered the price target on Stemline Therapeutics (NASDAQ: STML) to $23.00 (from $30.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Navios Maritime Partners (NMM) PT Raised to $100 at Jefferies
- Palmer Square Capital BDC (PSBD) PT Lowered to $10.25 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
